Description:

• Adipotide : is a new drug that has shown some promise in obesity research. The drug was originally created as a cancer treatment designed to starve cancer cells in the blood supply in order for them to stop growing. The effect of the lipid expelling drug showed that the drug actually starved fat cells in the blood, forcing them to die and be reabsorbed by the body. Initial tests were carried out on mice and then moved on to monkeys. Tests on rats showed a 30 percent weight loss. After four weeks of daily injections of Adipotide, followed by four weeks of no treatment, ten obese female rhesus macaques lost an average of 11% of their body weight and 39% fewer fat deposits. Most of the losses were experienced during the non-treatment period.
• The importance of peptides:
• Many active substances in the human body are in the form of peptides. Peptides are involved in various fields of human hormones, nerves, cell growth and reproduction, and their importance is to regulate the physiological functions of various systems and cells in the body, activate the relevant enzyme systems in the body, promote the permeability of intermediate metabolic membranes, or control DNA transcription or affect specific protein synthesis, and ultimately produce specific physiological effects. Peptides are important substances involved in various cell functions in human body. Peptides can be synthesized into cells and regulate their functional activities. Peptides act as neurotransmitters in the body, transmitting information. Peptides can be used as transportation tools in the human body to transport various nutrients and various vitamins, biotin, calcium and trace elements beneficial to the human body to the cells, organs and tissues of the human body. Peptide is an important physiological regulator of the human body, which can comprehensively regulate the physiological function of the human body, enhance and exert the physiological activity of the human body, and it has important biological functions.

Application: FOR WEIGHT LOSS